Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Ray WA, Griffin MR, Downey W (1989) JAMA 262: 3303-7 Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD, Wickman K (2014) Proc Natl Acad Sci U S A 111: 10755-60 Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. Bedse G, Hartley ND, Neale E, Gaulden AD, Patrick TA, Kingsley PJ, Uddin MJ, Plath N, Marnett LJ, Patel S (2017) Biol Psychiatry 82: 488-499 The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. Patel S, Shonesy BC, Bluett RJ, Winder DG, Colbran RJ (2016) Biol Psychiatry 79: e78-e79 Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects. Gould RW, Amato RJ, Bubser M, Joffe ME, Nedelcovych MT, Thompson AD, Nickols HH, Yuh JP, Zhan X, Felts AS, Rodriguez AL, Morrison RD, Byers FW, Rook JM, Daniels JS, Niswender CM, Conn PJ, Emmitte KA, Lindsley CW, Jones CK (2016) Neuropsychopharmacology 41: 1166-78 Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids. Gunduz-Cinar O, Flynn S, Brockway E, Kaugars K, Baldi R, Ramikie TS, Cinar R, Kunos G, Patel S, Holmes A (2016) Neuropsychopharmacology 41: 1598-609 Dopamine receptor antagonism by the novel antianxiety drug, buspirone. McMillen BA, Matthews RT, Sanghera MK, Shepard PD, German DC (1983) J Neurosci 3: 733-8 Experimental model for functional magnetic resonance imaging of somatic sensory cortex in the unanesthetized rat. Sachdev RN, Champney GC, Lee H, Price RR, Pickens DR, Morgan VL, Stefansic JD, Melzer P, Ebner FF (2003) Neuroimage 19: 742-50 Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. Engers JL, Rodriguez AL, Konkol LC, Morrison RD, Thompson AD, Byers FW, Blobaum AL, Chang S, Venable DF, Loch MT, Niswender CM, Daniels JS, Jones CK, Conn PJ, Lindsley CW, Emmitte KA (2015) J Med Chem 58: 7485-500 Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity. Rodriguez AL, Grier MD, Jones CK, Herman EJ, Kane AS, Smith RL, Williams R, Zhou Y, Marlo JE, Days EL, Blatt TN, Jadhav S, Menon UN, Vinson PN, Rook JM, Stauffer SR, Niswender CM, Lindsley CW, Weaver CD, Conn PJ (2010) Mol Pharmacol 78: 1105-23 Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. Dougherty M, DeBaun MR (2003) J Pediatr 142: 373-6 Benzodiazepines and the risk of falls in nursing home residents. Ray WA, Thapa PB, Gideon P (2000) J Am Geriatr Soc 48: 682-5 VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Nickols HH, Yuh JP, Gregory KJ, Morrison RD, Bates BS, Stauffer SR, Emmitte KA, Bubser M, Peng W, Nedelcovych MT, Thompson A, Lv X, Xiang Z, Daniels JS, Niswender CM, Lindsley CW, Jones CK, Conn PJ (2016) J Pharmacol Exp Ther 356: 123-36 Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. Galici R, Jones CK, Hemstapat K, Nong Y, Echemendia NG, Williams LC, de Paulis T, Conn PJ (2006) J Pharmacol Exp Ther 318: 173-85 Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Ray WA, Thapa PB, Gideon P (2002) Pharmacoepidemiol Drug Saf 11: 663-9 5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Rasmusson AM, Goldstein LE, Deutch AY, Bunney BS, Roth RH (1994) Synapse 18: 218-24 Recurring episodes of Bell's mania after cerebrovascular accident. Bobo WV, Murphy MJ, Heckers SH (2009) Psychosomatics 50: 285-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.